<!DOCTYPE html>
<!-- Generated by Aspose.Words for .NET 22.2.0 --><html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>fedlex-data-admin-ch-eli-fga-2022-1262-it-docx</title>
</head>
<body><div id="lawcontent"><div id="preface">
<h1 class="erlasstitel botschafttitel ">Notifiche e domande d’autorizzazione per attività in sistemi <br>chiusi con organismi geneticamente modificati o patogeni</h1>
<p class="untertit ">Notifiche e domande d’autorizzazione pervenute <br>dal 01.01.2022 al 30.04.2022</p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p>Numero</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>Data d’arrivo</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>Cantone di domicilio</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>Richiedente /<br>Sede legale</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>Titolo, in breve, del progetto</p>
				</th>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A000158-01</p>
				</td>
				<td>
					
					<p>10.01.2022</p>
				</td>
				<td>
					
					<p>SO</p>
				</td>
				<td>
					
					<p>Fabrizio Gorla<br>IMP Bautest AG<br>Laborweg 1<br>4625 Oberbuchsiten</p>
				</td>
				<td>
					
					<p>Bakteriologische Untersuchung von Trinkwasser</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A000309-02</p>
				</td>
				<td>
					
					<p>07.03.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Nickel Beatrice<br>Swiss Tropical and <br>Public Health Institute<br>Kreuzstrasse 2<br>4123 Allschwil</p>
				</td>
				<td>
					
					<p>Antigenproduktion für die Immundiagnostik</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A000384-02</p>
				</td>
				<td>
					
					<p>14.01.2022</p>
				</td>
				<td>
					
					<p>SZ</p>
				</td>
				<td>
					
					<p>Beat Kollöffel<br>Laboratorium der Urkantone<br>Föhneneichstrasse<br>6440 Brunnen</p>
				</td>
				<td>
					
					<p>Mikrobiologische Untersuchung von Lebensmittel-, Wasser- und Umweltproben</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A000631-03</p>
				</td>
				<td>
					
					<p>24.01.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Azeddine Elhajouji<br>Novartis Pharma AG<br>Postfach<br>4002 Basel</p>
				</td>
				<td>
					
					<p>Handling of human specimens (blood, urine and tissues) for genetic and pharmacogenomic studies</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A010019-04</p>
				</td>
				<td>
					
					<p>16.02.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Nadine Gerber<br>Kantonales Labor Zürich<br>Fehrenstrasse<br>8032 Zürich</p>
				</td>
				<td>
					
					<p>Mikrobiologische Unter­suchung von Lebensmittel-, Wasser- und Bodenproben <br>auf Shigatoxin produzierende Escherichia coli (STEC)</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A020124-02</p>
				</td>
				<td>
					
					<p>09.02.2022</p>
				</td>
				<td>
					
					<p>SO</p>
				</td>
				<td>
					
					<p>Marisa Reichenbecher<br>Eurofins Scientific AG, Schönenwerd<br>Parkstrasse 10<br>5012 Schönenwerd</p>
				</td>
				<td>
					
					<p>Mikrobiologische Reinheitsprüfung von Lebensmitteln, Kosmetika und Pharmazeutika, sowie Konservierungsmittelbelastungstests und Antibiotika-Gehaltsbestimmungen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A050654-03</p>
				</td>
				<td>
					
					<p>15.02.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Urs Jenal<br>Universität Basel, Biozentrum / Pharma­zentrum<br>Spitalstrasse 41<br>4056 Basel</p>
				</td>
				<td>
					
					<p>Regulation von Biofilm­bildung und Persistenz in Pseudomonas aeruginosa</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A080056-03</p>
				</td>
				<td>
					
					<p>22.01.2022</p>
				</td>
				<td>
					
					<p>BS, <br>BL</p>
				</td>
				<td>
					
					<p>Gerd Pluschke<br>Swiss Tropical and <br>Public Health Institute<br>Socinstrasse<br>4002 Basel</p>
				</td>
				<td>
					
					<p>Kultivierung von Mycobacterium ulcerans Stämmen zur Entwicklung neuer diagnostischer Methoden und Therapieansätze;</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A090140-04</p>
				</td>
				<td>
					
					<p>15.03.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Adriano Aguzzi<br>USZ, Institut für Neuro­pathologie<br>Schmelzbergstrasse<br>8091 Zürich</p>
				</td>
				<td>
					
					<p>Lentiviral gene-transfer in vitro</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A100320-09</p>
				</td>
				<td>
					
					<p>01.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Annelies S. Zinkernagel<br>USZ, Klinik für Infektionskrankheiten und Spitalhygiene, Bakterio­logie<br>Rämistrasse<br>8091 Zürich</p>
				</td>
				<td>
					
					<p>Untersuchung von Wirt Bakterien Interaktionen in vitro und in vivo</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A100457-04</p>
				</td>
				<td>
					
					<p>22.02.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Christian Wolfrum<br>ETHZ, Departement HEST, Institute of Food, Nutrition and Health<br>Schorenstrasse<br>8603 Schwerzenbach</p>
				</td>
				<td>
					
					<p>Virale Infektion von Zellkultur und Mausmodellen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A110049-03</p>
				</td>
				<td>
					
					<p>11.04.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Cinzia Zehnder<br>Synlab Suisse Tessin<br>Pianon 7<br>6934 Bioggio</p>
				</td>
				<td>
					
					<p>Laboratorio di analisi mediche</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A110122-02</p>
				</td>
				<td>
					
					<p>28.03.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Valentina Cecchinato<br>Institute for Research in Biomedicine<br>via Francesco Chiesa 5<br>6500 Bellinzona</p>
				</td>
				<td>
					
					<p>Migration and Differentiation of Th17 cells in HAART-naive HIV-H patients</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A110549-04</p>
				</td>
				<td>
					
					<p>07.03.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Gwendoline Wicki<br>InSphero AG<br>Wagistrasse 27A<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Entwicklung und Produktion von 3D Zellkulturmodellen aus tierischen und menschlichen Zell-Linien und Primärzellen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A110654-04</p>
				</td>
				<td>
					
					<p>01.03.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Olivier Engler<br>Labor Spiez<br>Austrasse<br>3700 Spiez</p>
				</td>
				<td>
					
					<p>Entwicklung von Nachweismethoden und Analytik von viralen Erregern der Risikogruppe 4 (klinische Proben, Umweltproben inkl. bioterroristische Verdachtsproben) sowie Evaluation von antiviralen Substanzen, neutralisierenden Antikörpern und\$ Dekontaminatio</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A120518-01</p>
				</td>
				<td>
					
					<p>07.02.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Greta Guarda<br>Institute for Research in Biomedicine<br>via Francesco Chiesa 5<br>6500 Bellinzona</p>
				</td>
				<td>
					
					<p>Utilisation de vecteurs rétroviraux et lentiviraux pour l’expression de transgènes, et de vecteurs lentiviraux pour réduire l’expression de gènes dans des cellules en culture (shRNA)</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A120803-06</p>
				</td>
				<td>
					
					<p>10.01.2022</p>
				</td>
				<td>
					
					<p>SO</p>
				</td>
				<td>
					
					<p>Ellen Braksator<br>bSys GmbH<br>Benkenstrasse<br>4108 Witterswil</p>
				</td>
				<td>
					
					<p>Beforschung, Herstellung und Lagerung von genetisch modifizierten Zelllinien</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A120851-23</p>
				</td>
				<td>
					
					<p>28.03.2022</p>
				</td>
				<td>
					
					<p>VD, <br>GE</p>
				</td>
				<td>
					
					<p>Brian McCabe<br>EPFL – SV Faculté des sciences de la vie<br>Station 19<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>Recherche en sciences de la vie</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A130500-03</p>
				</td>
				<td>
					
					<p>18.01.2022</p>
				</td>
				<td>
					
					<p>BS, <br>BL</p>
				</td>
				<td>
					
					<p>Sergio Wittlin<br>Swiss Tropical and Public Health Institute<br>Socinstrasse<br>4002 Basel</p>
				</td>
				<td>
					
					<p>Testen der Antimalariawirkung ausgesuchter Leitsubstanzen in einem Plasmodium falciparum-Mausmodell</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A130556-07</p>
				</td>
				<td>
					
					<p>05.01.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Jean-Christophe Leroux<br>ETHZ, Departement CHAB, Institut für Pharmazeutische Wissenschaften, Drug formulation + delivery<br>Vladimir Prelog-<br>Weg 1-5/10<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Globalmeldung der ETH Zürich, Gruppe Leroux</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A130556-08</p>
				</td>
				<td>
					
					<p>11.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Jean-Christophe Leroux<br>ETHZ, Departement CHAB, Institut für Pharmazeutische Wissenschaften, Drug formulation + delivery<br>Vladimir Prelog-Weg 1-5/10<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Globalmeldung der ETH Zürich, Gruppe Leroux</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A130601-02</p>
				</td>
				<td>
					
					<p>07.02.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Greta Guarda<br>Institute for Research in Biomedicine<br>via Francesco Chiesa 5<br>6500 Bellinzona</p>
				</td>
				<td>
					
					<p>Etude de la réponse antivirale dans les souris knockout</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A131018-07</p>
				</td>
				<td>
					
					<p>24.02.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Susan Mango<br>Universität Basel, Biozentrum / Pharma­zentrum<br>Spitalstrasse 41<br>4056 Basel</p>
				</td>
				<td>
					
					<p>Molekulare Biologie am Biozentrum/Pharmazentrum</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A131034-02</p>
				</td>
				<td>
					
					<p>14.03.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Christoph Graf<br>Kantonales Laboratorium BE<br>Muesmattstrasse<br>3012 Bern</p>
				</td>
				<td>
					
					<p>Lagerung lebender GVO-Organismen als Standard für Untersuchung von Lebensmitteln auf GVO</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A140535-02</p>
				</td>
				<td>
					
					<p>20.04.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Mauro Tonolla<br>Istituto Microbiologia<br>via Mirasole<br>6500 Bellinzona</p>
				</td>
				<td>
					
					<p>Identificazioni e tipizzazioni di microoranismi classe 2</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A141238-02</p>
				</td>
				<td>
					
					<p>05.04.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Sylvia Rothenberger Aubert<br>CHUV – Centre hospitalier universitaire vaudois<br>Bugnon 48<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>Studies of viral cell entry of Lassa and Hantaanvirus using vesicular stomatitis virus pseudotypes</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A150519-02</p>
				</td>
				<td>
					
					<p>06.04.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Ping-Chih Ho<br>University of Lausanne | Department of Fundamental Oncology | Ludwig Center for Cancer Research<br>Ch. des Boveresses<br>1066 Epalinges</p>
				</td>
				<td>
					
					<p>Optimizing T cell-based cancer immunotherapy</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A151445-03</p>
				</td>
				<td>
					
					<p>16.02.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Vincent Trebosc<br>BioVersys AG<br>Hochbergerstrasse<br>4057 Basel</p>
				</td>
				<td>
					
					<p>Erweiterung des Tätigkeitsbereiches um Enterobacteriaceae und Galleria mellonella</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A151545-01</p>
				</td>
				<td>
					
					<p>01.02.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Paolo Paganetti<br>Ente Ospedaliero Cantonale EOC | Laboratories for Translational Research (LRT)<br>via Chiesa 5<br>6500 Bellinzona</p>
				</td>
				<td>
					
					<p>Attività classe 1 – LBN</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A151556-03</p>
				</td>
				<td>
					
					<p>25.03.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Martin Ackermann<br>ETHZ | Wasserforschungsinstitut EAWAG<br>Überlandstrasse 133<br>8600 Dübendorf</p>
				</td>
				<td>
					
					<p>Molecular and general microbiology with bacterial pathogens in the Molecular Microbial Ecology group at Eawag</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A151578-01</p>
				</td>
				<td>
					
					<p>01.04.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Christopher Farady<br>Novartis Pharma AG<br>Postfach<br>4002 Basel</p>
				</td>
				<td>
					
					<p>Overexpressing and knocking-down inflammatory genes and proteins in macrophages by viral vectors</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A151583-02</p>
				</td>
				<td>
					
					<p>07.03.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Tijmen Booij<br>ETHZ, NEXUS Personalized Health Technology<br>Otto-Stern-Weg<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Produktion von lentiviralen Partikeln für shRNA und CRISPR/Cas 9 Experimente sowie von Organoiden</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A161724-01</p>
				</td>
				<td>
					
					<p>25.01.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Proletina Minkova<br>UNILABS (Dübendorf)<br>Ringstrasse 12<br>8600 Dübendorf</p>
				</td>
				<td>
					
					<p>Meldung der gelagerten Isolate</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A161739-01</p>
				</td>
				<td>
					
					<p>07.02.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Greta Guarda<br>Institute for Research in Biomedicine<br>via Francesco Chiesa 5<br>6500 Bellinzona</p>
				</td>
				<td>
					
					<p>Etude de gènes d’intérêt dans les cellules et dans la souris</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A161815-02</p>
				</td>
				<td>
					
					<p>10.02.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Daniela Lachat<br>Novartis Pharma AG<br>Postfach<br>4002 Basel</p>
				</td>
				<td>
					
					<p>Whole genome CRISPR screen (Chinese hamster)</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A161825-07</p>
				</td>
				<td>
					
					<p>10.02.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Laurent Keller<br>UNIL – Département Ecologie et évolution (DEE)<br>Biophore<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>UNIL_DEE_Notification globale de niveau 1</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A161878-02</p>
				</td>
				<td>
					
					<p>21.04.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Carolina Obregon Espinel<br>CHUV – Centre hospitalier universitaire vaudois<br>Bugnon 27<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>Rôle des cellules dans les mécanismes d’inflammation et cross-talk</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A172013-04</p>
				</td>
				<td>
					
					<p>23.02.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Thomas Böddeker<br>ETHZ, Departement MATL, Soft and Living Materials, Gruppe Dufresne<br>Vladimir-Prelog-Weg<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Global Notification Class I</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A172015-01</p>
				</td>
				<td>
					
					<p>28.04.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Annick Muhlethaler<br>CHUV – Centre hospitalier universitaire vaudois<br>Rue du Bugnon 25<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>Molecular mechanisms of NB aggressiveness</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A172022-01</p>
				</td>
				<td>
					
					<p>23.03.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Markus Heim<br>Departement Biomedizin (DBM), Hebelstrasse, Universitätsspital Basel<br>Hebelstrasse<br>4031 Basel</p>
				</td>
				<td>
					
					<p>Analysis of Hepatitis E virus-host interactions</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A172051-01</p>
				</td>
				<td>
					
					<p>06.04.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Viktoria Reinmüller</p>
					<p>Auxenion Research AG<br>Gewerbestrasse<br>4123 Allschwil</p>
				</td>
				<td>
					
					<p>Forschung</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A172128-04</p>
				</td>
				<td>
					
					<p>25.03.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Christian-Benedikt Gerhold<br>Bühlmann Laboratories AG<br>Baselstrasse 55<br>4124 Schönenbuch</p>
				</td>
				<td>
					
					<p>rekombinante Proteinexpression</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A182321-01</p>
				</td>
				<td>
					
					<p>24.01.2022</p>
				</td>
				<td>
					
					<p>BS, <br>BL</p>
				</td>
				<td>
					
					<p>Pascal Mäser<br>Swiss Tropical and <br>Public Health Institute<br>Socinstrasse<br>4002 Basel</p>
				</td>
				<td>
					
					<p>Screening in vitro von synthetischen Molekülen und Naturstoffen gegen Trypanosoma cruzi</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A192702-04</p>
				</td>
				<td>
					
					<p>17.03.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Michael Brück<br>Sefunda AG<br>Hofackerstrasse<br>4132 Muttenz</p>
				</td>
				<td>
					
					<p>Assayentwicklung zur Detektion übertragbarer Krankheiten</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A192721-01</p>
				</td>
				<td>
					
					<p>19.02.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Damien Portevin<br>Swiss Tropical and <br>Public Health Institute<br>Kreuzstrasse 2<br>4123 Allschwil</p>
				</td>
				<td>
					
					<p>Experimental manipulation <br>of attenuated Mycobacterium tuberculosis subsp., H37Ra</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A202784-01</p>
				</td>
				<td>
					
					<p>16.04.2022</p>
				</td>
				<td>
					
					<p>AR</p>
				</td>
				<td>
					
					<p>Max Känzig<br>Tierarztpraxis <br>Im Bad AG<br>Badstrasse<br>9410 Heiden</p>
				</td>
				<td>
					
					<p>Bewilligung zur Durchführung von bakteriologischen Milchproben</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A202921-03</p>
				</td>
				<td>
					
					<p>25.01.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Caroline Tapparel Vu<br>Université de Genève, CMU (Centre Médical Universitaire)<br>1, rue Michel Servet<br>1206 Geneva</p>
				</td>
				<td>
					
					<p>Antiviral activity against Coronaviruses</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A202923-01</p>
				</td>
				<td>
					
					<p>29.03.2022</p>
				</td>
				<td>
					
					<p>OW</p>
				</td>
				<td>
					
					<p>Tiziano Balmelli<br>Synlab Suisse D-CH<br>Brünigstrasse 181<br>6060 Sarnen</p>
				</td>
				<td>
					
					<p>SYNLAB Sarnen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A202958-02</p>
				</td>
				<td>
					
					<p>18.01.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Annette Ives<br>AC Bioscience SA<br>route de la Corniche<br>1066 Epalinges</p>
				</td>
				<td>
					
					<p>Screening of drug candidates</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A203012-01</p>
				</td>
				<td>
					
					<p>06.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Gudrun Winter<br>Zimmer Switzerland Manufacturing GmbH<br>Sulzer-Allee<br>8404 Winterthur</p>
				</td>
				<td>
					
					<p>Mikrobiologische Untersuchung von Medizinprodukten und deren Herstellungsbereichen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A203032-03</p>
				</td>
				<td>
					
					<p>08.02.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Urs Greber<br>Universität Zürich <br>Department of Molecular Life Sciences<br>Schmelzbergstrasse 12<br>8091 Zürich</p>
				</td>
				<td>
					
					<p>Validation screen of clinical compounds against SARS-CoV-2 with high repurposing potential against COVID-19</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A203134-02</p>
				</td>
				<td>
					
					<p>18.01.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Roger Geiger<br>Institute for Research in Biomedicine<br>via Francesco Chiesa 5<br>6500 Bellinzona</p>
				</td>
				<td>
					
					<p>Gene editing with CRISPR-Cas9 for functional analyses in immune cells </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A203135-02</p>
				</td>
				<td>
					
					<p>18.01.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Roger Geiger<br>Institute for Research in Biomedicine<br>via Francesco Chiesa 5<br>6500 Bellinzona</p>
				</td>
				<td>
					
					<p>Use of replication-deficient lentiviral and retroviral vectors to engineer murine and human immune cells in vitro </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A203149-01</p>
				</td>
				<td>
					
					<p>25.04.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Valeria Cagno<br>CHUV – Centre hospitalier universitaire vaudois<br>Rue du Bugnon 48<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>Antiviral discovery</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A203150-01</p>
				</td>
				<td>
					
					<p>22.02.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Kateryna Tolmachova<br>ETHZ, Departement CHAB, Laboratorium für Organische Chemie, Bode group | Labs HCI F302 and HCI E320<br>Vladimir-Prelog-Weg<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>BSL1 cell culture research activities of the Bode group, LOC, ETHZ</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A203153-01</p>
				</td>
				<td>
					
					<p>08.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Cameron Boggon<br>ETHZ, Departement MATL, Laboratory of Soft Materials and Interfaces<br>Vladimir-Prelog-Weg 5<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Antibiotic Persistence in Staphylococcus aureus</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210123-01</p>
				</td>
				<td>
					
					<p>29.03.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Alejandro Ocampo Méndez<br>UNIL – Département des Sciences Biomédicales<br>Bugnon<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>Identification of novel factors for the reprogramming of aging</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210130-01</p>
				</td>
				<td>
					
					<p>08.03.2022</p>
				</td>
				<td>
					
					<p>JU</p>
				</td>
				<td>
					
					<p>Philip Weyl<br>CABI<br>Rue des Grillons<br>2800 Delémont</p>
				</td>
				<td>
					
					<p>Biological control of Parrots feather, Myriophyllum aquaticum</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210136-02</p>
				</td>
				<td>
					
					<p>25.01.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Karl-Heinz Krause<br>Université de Genève, CMU (Centre Médical Universitaire)<br>1, rue Michel Servet<br>1206 Geneva</p>
				</td>
				<td>
					
					<p>Testing of antivirals against Coronaviruses</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210153-01</p>
				</td>
				<td>
					
					<p>19.02.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Nicolas Brancucci<br>Swiss Tropical and Public Health Institute<br>Kreuzstrasse 2<br>4123 Allschwil</p>
				</td>
				<td>
					
					<p>Deciphering Environmental Sensing in Malaria Parasites</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210203-03</p>
				</td>
				<td>
					
					<p>23.02.2022</p>
				</td>
				<td>
					
					<p>TG, <br>ZH, <br>GR, <br>OW</p>
				</td>
				<td>
					
					<p>Thomas Krech<br>DiAMiSANTO GmbH<br>Murgstrasse 2, Korrespondenzadresse: Rheinstrasse 1<br>8500 Frauenfeld</p>
				</td>
				<td>
					
					<p>Prof. MD</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210253-01</p>
				</td>
				<td>
					
					<p>22.02.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Margherita Turco<br>Friedrich Miescher Institute for Biomedical Research<br>Maulbeerstrasse 66<br>4058 Basel</p>
				</td>
				<td>
					
					<p>Investigating human placental development and its interactions with the maternal uterine microenvironment</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210291-01</p>
				</td>
				<td>
					
					<p>27.04.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Joana Silva<br>Novartis Pharma AG<br>Postfach<br>4002 Basel</p>
				</td>
				<td>
					
					<p>Loss of function shRNA screens to identify sensitizers to radiation</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210365-02</p>
				</td>
				<td>
					
					<p>02.02.2022</p>
				</td>
				<td>
					
					<p>FR</p>
				</td>
				<td>
					
					<p>Heinz Müller Schärer<br>Université de Fribourg, Département de Biologie<br>Chemin du Musée<br>1700 Fribourg</p>
				</td>
				<td>
					
					<p>Keimungsverhalten von drüsigem Springkraut (Impatiens glandulifera)</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220001-01</p>
				</td>
				<td>
					
					<p>25.01.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Mirco Schmolke<br>Université de Genève, CMU (Centre Médical Universitaire)<br>1 Rue Michel Servet<br>1211 Genève</p>
				</td>
				<td>
					
					<p>Identification of host proteins involved in early steps of Coronavirus replication</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220002-00</p>
				</td>
				<td>
					
					<p>04.01.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Xavier Garrabou Pi<br>Lock and Key <br>Bio­sciences GmbH<br>Otto-Stern-Weg 7<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Preparation of plasmids <br>for bacterial expression of proteins with ProteoShell</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220003-00</p>
				</td>
				<td>
					
					<p>04.01.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Martin Hausmann<br>UniversitätsSpital Zürich, Klinik für Gastroenterologie und Hepatologie</p>
					<p>Wagistrasse<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Zoonosen – Inokulation von Nagern mit E. multilocularis Eiern</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220004-00</p>
				</td>
				<td>
					
					<p>04.01.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Simon Zenke<br>Ridgeline Discovery GmbH<br>Hochbergerstrasse 60C, Technologiepark<br>4057 Basel</p>
				</td>
				<td>
					
					<p>Virus production</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220005-00</p>
				</td>
				<td>
					
					<p>05.01.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Duygu Istanbullu<br>USZ, Research Biobanking Service Center<br>Rämistrasse 100<br>8091 Zürich</p>
				</td>
				<td>
					
					<p>Test</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220006-01</p>
				</td>
				<td>
					
					<p>31.01.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Steve Pascolo<br>USZ, Dermatologische Klinik<br>Wagistrasse 18<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Transfection of primary cells and tumour cell lines with RNA nanoparticles</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220007-00</p>
				</td>
				<td>
					
					<p>07.01.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Serina Robinson<br>ETHZ | Wasserforschungsinstitut EAWAG<br>Überlandstrasse 133<br>8600 Dübendorf</p>
				</td>
				<td>
					
					<p>Growth of wastewater isolates on organic pollutants</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220008-00</p>
				</td>
				<td>
					
					<p>07.01.2022</p>
				</td>
				<td>
					
					<p>AG</p>
				</td>
				<td>
					
					<p>Xavier Deupi<br>Paul Scherrer Institut, Biomolekulare Forschung<br>-<br>5232 Villigen PSI</p>
				</td>
				<td>
					
					<p>Global aotification of BSL-1 activities</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220009-00</p>
				</td>
				<td>
					
					<p>07.01.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Duygu Istanbullu<br>USZ, Research Biobanking Service Center<br>Rämistrasse 100<br>8091 Zürich</p>
				</td>
				<td>
					
					<p>USZ BioResource Biobank – Storage service of samples for research groups</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220010-00</p>
				</td>
				<td>
					
					<p>10.01.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Daniel Ritz<br>Idorsia Pharmaceuticals Ltd.<br>Hegenheimermattweg 89<br>4123 Allschwil</p>
				</td>
				<td>
					
					<p>Antiviral susceptibility testing and characterization of compounds against HCoV</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220012-00</p>
				</td>
				<td>
					
					<p>11.01.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Sonja Lehtinen<br>ETHZ, Departement USYS, Institute of Integrative Biology (IBZ) | Theoretische Biologie<br>Universitätsstrasse 16,<br>8092 Zürich</p>
				</td>
				<td>
					
					<p>Diversity and dynamics of Escherichia coli in the human gut</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220013-01</p>
				</td>
				<td>
					
					<p>18.03.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Tobias Broger<br>Avelo AG<br>Rütistrasse 16<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>220112_Gesuch1</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220014-00</p>
				</td>
				<td>
					
					<p>13.01.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Olivier Braissant<br>Universitätsspital Basel + University of Basel, Dept. biomedical Engineering (DBE)<br>Gewerbestrasse 14-16<br>4123 Allschwil</p>
				</td>
				<td>
					
					<p>Developpment of new diagnostic and susceptibility testing method for clinical, environmental and material samples</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220015-00</p>
				</td>
				<td>
					
					<p>18.01.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Annette Ives<br>AC Bioscience SA<br>route de la Corniche<br>1066 Epalinges</p>
				</td>
				<td>
					
					<p>Screening of drug compounds for anti-i^nfective capacity</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220016-00</p>
				</td>
				<td>
					
					<p>19.01.2022</p>
				</td>
				<td>
					
					<p>FR</p>
				</td>
				<td>
					
					<p>Heinz Müller Schärer<br>Université de Fribourg, Département de Biologie<br>Chemin du Musée<br>1700 Fribourg</p>
				</td>
				<td>
					
					<p>Keimungsverhalten von drüsigem Springkraut <br>(Impatiens glandulifera)</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220017-00</p>
				</td>
				<td>
					
					<p>19.01.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Francesco Origgi<br>Universität Bern | Institut für Tierpathologie<br>Länggassstrasse<br>3012 Bern</p>
				</td>
				<td>
					
					<p>Development of serological test for exposure detection of Ophidiomyces ophiodiicola in free ranging snakes</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220018-00</p>
				</td>
				<td>
					
					<p>21.01.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Nina Khanna<br>Departement Biomedizin (DBM), Hebelstrasse, Universitätsspital Basel<br>Hebelstrasse<br>4031 Basel</p>
				</td>
				<td>
					
					<p>Development of EBV specific Cell therapy</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220019-00</p>
				</td>
				<td>
					
					<p>21.01.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Simon Anderhub<br>SGS Analytics Switzerland AG<br>Sternenfeldstrasse 14<br>4127 Birsfelden</p>
				</td>
				<td>
					
					<p>MP0420 Pseudovirusassay (SGS Projekt ID SPI_S_21037)</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220020-01</p>
				</td>
				<td>
					
					<p>24.03.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Carolyn King</p>
					<p>Departement Biomedizin (DBM), Hebelstrasse, Universitätsspital Basel<br>Spitalstrasse 41<br>4056 Basel</p>
				</td>
				<td>
					
					<p>Mycobacterium tuberculosis for use in vitro and in mouse models</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220021-00</p>
				</td>
				<td>
					
					<p>24.01.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Frank Bantleon<br>Bühlmann Laboratories AG<br>Baselstrasse 55<br>4124 Schönenbuch</p>
				</td>
				<td>
					
					<p>rekombinante Zellexpression</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220022-00</p>
				</td>
				<td>
					
					<p>25.01.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Laurent Keller<br>UNIL – Département Ecologie et évolution (DEE)<br>Biophore<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>UNIL_DEE_Notification globale de niveau 1</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220023-00</p>
				</td>
				<td>
					
					<p>25.01.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Hardowin Wolhoff<br>UNILABS (Dübendorf)<br>Asylstrasse 19<br>8810 Horgen</p>
				</td>
				<td>
					
					<p>Medizinisch-molekularbiologische Diagnostik</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220024-00</p>
				</td>
				<td>
					
					<p>26.01.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Benoit Gering<br>Bracco Suisse SA<br>route de la Galaise<br>1228 Plan-les-Ouates</p>
				</td>
				<td>
					
					<p>Notification globale d’activités de classe 1</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220025-00</p>
				</td>
				<td>
					
					<p>26.01.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Massimo Lopes<br>Universität Zürich <br>Institute of Molecular Cancer Research (IMCR)<br>Winterthurerstrasse<br>8057 Zürich</p>
				</td>
				<td>
					
					<p>NON-CANONICAL MECHANISMS OF BREAST TUMORIGENESIS IN BRCA2 MUTATION CARRIERS</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220026-00</p>
				</td>
				<td>
					
					<p>27.01.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Nathalie Roussianos<br>Bactolab SA<br>Avenue des Bains 6<br>1007 Lausanne</p>
				</td>
				<td>
					
					<p>laboratoire d’analyse medicale</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220027-00</p>
				</td>
				<td>
					
					<p>27.01.2022</p>
				</td>
				<td>
					
					<p>NE</p>
				</td>
				<td>
					
					<p>Lucia Eugeni Piller<br>Service de la consommation et des affaires vétérinaires (SCAV)<br>5, rue Jehanne-de-Hochberg<br>2001 Neuchâtel 1</p>
				</td>
				<td>
					
					<p>Analyse du SARS-CoV-2 dans les eaux usées</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220028-00</p>
				</td>
				<td>
					
					<p>31.01.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Jirasko Vlastimil<br>ETH Zürich, Gruppe <br>Prof. Janos Vörös<br>Gloriastrasse 35<br>8092 Zürich</p>
				</td>
				<td>
					
					<p>Nachweis SARS-CoV-2 mit Antikörper</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220029-00</p>
				</td>
				<td>
					
					<p>31.01.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Andrea Cavalli<br>Institute for Research in Biomedicine<br>via Francesco Chiesa 5<br>6500 Bellinzona</p>
				</td>
				<td>
					
					<p>Study of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) using pseudoviruses. </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220030-00</p>
				</td>
				<td>
					
					<p>01.02.2022</p>
				</td>
				<td>
					
					<p>FR</p>
				</td>
				<td>
					
					<p>Michael Walch<br>Université de Fribourg | Faculté des sciences et de médecine | Département d’Oncologie, Microbiologie et Immunologie | Chaire de Microbiologie<br>Chemin du Musée 18 – PER17<br>1700 Fribourg</p>
				</td>
				<td>
					
					<p>Characterisation of immune defense mechanisms against pathogenic bacteria in vitro and in vivo</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220031-00</p>
				</td>
				<td>
					
					<p>02.02.2022</p>
				</td>
				<td>
					
					<p>LU</p>
				</td>
				<td>
					
					<p>Jivko Stoyanov<br>Schweizer Paraplegiker Zentrum<br>Guido A. Zächstrasse<br>6207 Nottwil</p>
				</td>
				<td>
					
					<p>Die Auswirkungen einer probiotischen Nahrungsergänzung auf Spitzensportler mit Rückenmarksverletzungen (RMV)</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220032-00</p>
				</td>
				<td>
					
					<p>04.02.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Barbara Schnell<br>Dr Risch AG Hirslanden Klinik LInde<br>Blumenrain 105<br>2501 Biel</p>
				</td>
				<td>
					
					<p>Bakteriologische Labor <br>(Spitallabor)</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220033-00</p>
				</td>
				<td>
					
					<p>04.02.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Thomas Bodmer<br>Dr Risch arc lémanique SA<br>Chemin de l’Esparcette 10<br>1023 Crissier</p>
				</td>
				<td>
					
					<p>Medizinisch Diagnostisches Labor</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220034-00</p>
				</td>
				<td>
					
					<p>08.02.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Aleksander Rebane<br>ETHZ, Departement MATL, Soft and Living Materials, Gruppe Dufresne<br>Vladimir-Prelog-Weg<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Recombinant protein purification from E. coli DE3 BL21</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220035-00</p>
				</td>
				<td>
					
					<p>08.02.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Souzan Salemi<br>USZ, Urologische Klinik<br>Wagistrasse 21<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>LentiCRISPRv2 </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220036-00</p>
				</td>
				<td>
					
					<p>09.02.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Christoph Dehio<br>Universität Basel, <br>Biozentrum / Pharma­zentrum<br>Spitalstrasse 41<br>4056 Basel</p>
				</td>
				<td>
					
					<p>Type-III-secretion assay for Yersinia enterocolitica dHOPEMT-asd in HeLa cells</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220037-00</p>
				</td>
				<td>
					
					<p>09.02.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Sarah Overall<br>ETHZ, Departement CHAB, Laboratorium für Physikalische Chemie (LPC), Gruppe Barnes<br>Vladimir-Prelog-Weg<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>PKC structural Biology</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220038-00</p>
				</td>
				<td>
					
					<p>09.02.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Martine Collart<br>Université de Genève, CMU (Centre Médical Universitaire)<br>1 Rue Michel Servet<br>1211 Genève</p>
				</td>
				<td>
					
					<p>Defining how the FKBP10 peptidyl prolyl cis-trans isomerase is essential for growth of lung cancer cells 1. How does the proposal fit in the field in which the proposal in pl</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220039-00</p>
				</td>
				<td>
					
					<p>10.02.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>MAGALI SCHNELL<br>KBI Biopharma SA<br>Route de la Galaise, 36<br>1228 PLAN LES OUATES</p>
				</td>
				<td>
					
					<p>LABORATOIRE D’ANALYSES MICROBIOLOGIQUES – BIOPHARMA</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220040-01</p>
				</td>
				<td>
					
					<p>25.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Christian Röhrig<br>Micreos GmbH Switzerland<br>Zugerstrasse 76<br>8820 Wädenswil</p>
				</td>
				<td>
					
					<p>Development of phage-based antimicrobials against bacteria</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220041-00</p>
				</td>
				<td>
					
					<p>10.02.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Sotirios Sotiriou<br>FoRx Therapeutics AG<br>Lichtstrasse<br>4056 Basel</p>
				</td>
				<td>
					
					<p>FoRx_Class2</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220042-00</p>
				</td>
				<td>
					
					<p>11.02.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Marc VOUILLAMOZ<br>KBI Biopharma SA<br>Route de la Galaise, 36<br>1228 PLAN LES OUATES</p>
				</td>
				<td>
					
					<p>Production et développement pharmaceutique à façon</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220043-00</p>
				</td>
				<td>
					
					<p>13.02.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Walter Reith<br>xSeedD Sàrl<br>1, rue Michel Servet<br>1206 Geneva</p>
				</td>
				<td>
					
					<p>In vitro assessment of therapeutical agents for human diseases</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220044-00</p>
				</td>
				<td>
					
					<p>14.02.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Maurizio Molinari<br>Institute for Research in Biomedicine<br>via Francesco Chiesa 5<br>6500 Bellinzona</p>
				</td>
				<td>
					
					<p>Gene editing with CRISPR-Cas9 for functional analyses in cultured and immune cells </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220045-00</p>
				</td>
				<td>
					
					<p>15.02.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Peter Keller<br>Universität Bern, <br>Institut für Infektions­krankheiten | Institut für Infektions­krankheiten<br>Freiburstrasse 3<br>3010 Bern</p>
				</td>
				<td>
					
					<p>Post-marketing microbiolo­gical surveillance of a water-free heater-cooler unit in cardiac surgery</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220046-00</p>
				</td>
				<td>
					
					<p>17.02.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Jana Collatz<br>Agroscope (Reckenholz)<br>Reckenholzstrasse<br>8046 Zürich</p>
				</td>
				<td>
					
					<p>Laborexperimente Dolichogenidea gelechiidivoris</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220047-00</p>
				</td>
				<td>
					
					<p>19.02.2022</p>
				</td>
				<td>
					
					<p>GR, <br>OW</p>
				</td>
				<td>
					
					<p>Thomas Krech<br>DiAMiSANTO GmbH<br>Via Murschetg 17<br>3032 Laax</p>
				</td>
				<td>
					
					<p>Aussenstandorte Laax und Sarnen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220048-00</p>
				</td>
				<td>
					
					<p>21.02.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Vladimir Katanaev<br>Université de Genève, CMU (Centre Médical Universitaire)<br>1 Rue Michel Servet<br>1211 Genève</p>
				</td>
				<td>
					
					<p>The Wnt signalling pathway and SARS-CoV-2: importance for lung infection and therapeutic potential</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220049-00</p>
				</td>
				<td>
					
					<p>22.02.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Thomas Michael Marti<br>Universität Bern, Department for BioMedical Research (DBMR)<br>Murtenstrasse 24<br>3008 Bern</p>
				</td>
				<td>
					
					<p>Targeting cellular plasticity <br>to eliminate cancer therapy resistance and metastasis by selective genetic inhibition or overexpression of key target genes in mouse and human cells with lentivirus vectors</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220050-00</p>
				</td>
				<td>
					
					<p>23.02.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Matthias Hofmann<br>Lonza AG, DPS<br>Hochbergerstrasse<br>4057 Basel</p>
				</td>
				<td>
					
					<p>Zelllinien basierte Assays </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220051-00</p>
				</td>
				<td>
					
					<p>01.03.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Dan Rohle<br>Ridgeline Discovery GmbH<br>Hochbergerstrasse 60C, Technologiepark<br>4057 Basel</p>
				</td>
				<td>
					
					<p>RedRidge Bio</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220052-00</p>
				</td>
				<td>
					
					<p>01.03.2022</p>
				</td>
				<td>
					
					<p>LU</p>
				</td>
				<td>
					
					<p>Daniela von Allmen<br>Andermatt Biocontrol Suisse AG<br>Stahlermatten 6<br>6146 Grossdietwil</p>
				</td>
				<td>
					
					<p>LC50 Test</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220053-00</p>
				</td>
				<td>
					
					<p>03.03.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Julie Bénis<br>Biosafe Group SA<br>Allée des moulins 3<br>1274 Grens</p>
				</td>
				<td>
					
					<p>Controle microbiologique pour la production de consommables médicaux</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220054-00</p>
				</td>
				<td>
					
					<p>04.03.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Urs Thomet<br>Anaxon AG<br>Bruennenstrasse 90<br>3018 Bern</p>
				</td>
				<td>
					
					<p>Biophysikalische Analytik gentechnisch optimierter Zelllinien</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220055-00</p>
				</td>
				<td>
					
					<p>08.03.2022</p>
				</td>
				<td>
					
					<p>SG</p>
				</td>
				<td>
					
					<p>Kerstin Kampa-Schittenhelm<br>Kantonsspital SG, Medizinisches Forschungszentrum (MFZ), Experimentelle Onkologie<br>Rorschacherstr.<br>9007 St. Gallen</p>
				</td>
				<td>
					
					<p>Mechanismen der Tumorentstehung und Metastasierung</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220056-00</p>
				</td>
				<td>
					
					<p>09.03.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Martin Brunner<br>Kantonales Labor Zürich<br>Fehrenstrasse 15<br>8032 Zürich</p>
				</td>
				<td>
					
					<p>Anzucht und Nachweis von Shigatoxin-bildenden E. coli für die Methodenentwicklung</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220057-00</p>
				</td>
				<td>
					
					<p>09.03.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Claudia Scheckel<br>Oncobit AG<br>Rütistrasse 16<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Development and performance of cancer diagnostics and monitoring assays</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220058-00</p>
				</td>
				<td>
					
					<p>10.03.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Sara Dias<br>Fondation campus Biotech Geneva<br>Chemin des Mines<br>1202 Genève</p>
				</td>
				<td>
					
					<p>A définir</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220059-00</p>
				</td>
				<td>
					
					<p>10.03.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Julie Bénis<br>Biosafe Group SA<br>route du petit Eysins 1<br>1262 Eysins</p>
				</td>
				<td>
					
					<p>Controle microbiologique pour la production de consommables médicaux</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220060-00</p>
				</td>
				<td>
					
					<p>10.03.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Lucio Barile<br>Ente Ospedaliero Cantonale EOC | Laboratories for Translational Research (LRT)<br>via Chiesa 5<br>6500 Bellinzona</p>
				</td>
				<td>
					
					<p>Use of cultured cells for biomedical research </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220061-01</p>
				</td>
				<td>
					
					<p>17.03.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Marine De Lageneste<br>Biosafe Group SA<br>Allée des moulins 3<br>1274 Grens</p>
				</td>
				<td>
					
					<p>Automatisation de thérapie cellulaire</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220063-00</p>
				</td>
				<td>
					
					<p>16.03.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Helge Abicht<br>IDEXX Switzerland GmbH | IDEXX Technologies GmbH<br>Stationsstrasse<br>3097 Liebefeld</p>
				</td>
				<td>
					
					<p>Optimization and Production of Tests for the Detection of Antibodies against MAP</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220064-00</p>
				</td>
				<td>
					
					<p>17.03.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Daniel Paris<br>Swiss Tropical and <br>Public Health Institute<br>Kreuzstrasse 2<br>4123 Allschwil</p>
				</td>
				<td>
					
					<p>Development of diagnostics and vaccines </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220065-00</p>
				</td>
				<td>
					
					<p>18.03.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Jochim Köser<br>Fachhochschule Nord­westschweiz | Hochschule für Life Sciences<br>Hofackerstrasse<br>4132 Muttenz</p>
				</td>
				<td>
					
					<p>Co-Detektion von MRSA und MSSA</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220066-00</p>
				</td>
				<td>
					
					<p>19.03.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Claudia Daubenberger<br>Swiss Tropical and <br>Public Health Institute<br>Kreuzstrasse 2<br>4123 Allschwil</p>
				</td>
				<td>
					
					<p>Pathogen molecular detection and analysis of vaccine and pathogen induced immunity in humans</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220067-00</p>
				</td>
				<td>
					
					<p>21.03.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>David Winkler<br>Universitätsspital Basel Pathologie / Medizinische Genetik<br>Schönbeinstrasse<br>4031 Basel</p>
				</td>
				<td>
					
					<p>Trans-seeding neurodegene­rative prion-like proteins by fungal, bacterial, viral and plant prions</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220068-00</p>
				</td>
				<td>
					
					<p>23.03.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Sophia Zeng<br>OPNA Immuno-<br>Oncology SA<br>OPNA Immuno-Oncology SA Biopôle 6, Route de la Corniche Bâtiment Serine<br>1066 Epalniges</p>
				</td>
				<td>
					
					<p>Lab Manager and safety Manager</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220069-00</p>
				</td>
				<td>
					
					<p>23.03.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Chiara Magnani<br>USZ, Klinik für Häma­tologie, Forschung<br>Rämistrasse 100<br>8091 Zürich</p>
				</td>
				<td>
					
					<p>Cancer immunotherapy with non-viral engineering of CAR T Cells</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220070-00</p>
				</td>
				<td>
					
					<p>24.03.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Urs Duthaler<br>Departement Biomedizin (DBM), Hebelstrasse, Universitätsspital Basel<br>Hebelstrasse<br>4031 Basel</p>
				</td>
				<td>
					
					<p>Bioanalytische Bestimmungen von human Plasmaproben</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220071-00</p>
				</td>
				<td>
					
					<p>24.03.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Alma Dal Co<br>UNIL – Département de biologie computationnelle (DBC)<br>13, route de Blévallaire<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>Salmonella SOS </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220072-00</p>
				</td>
				<td>
					
					<p>28.03.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Olivier Engler<br>Labor Spiez<br>Austrasse<br>3700 Spiez</p>
				</td>
				<td>
					
					<p>Transduktion einer Zellkultur mittels lentiviraler Bibliothek (Brunello) zur Identifizierung essentieller Gene für eine Krim-Kongo hämorrhagische Fieber Virus Infektion.</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220073-00</p>
				</td>
				<td>
					
					<p>29.03.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Alejandro Ocampo Méndez<br>UNIL – Département des Sciences Biomédicales<br>Bugnon<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>Evaluation of primary and secondary immune response at old age </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220074-00</p>
				</td>
				<td>
					
					<p>29.03.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Sophie Butot<br>Nestlé Centre de <br>recherche<br>Ruote du Jorat<br>1000 Lausanne 26</p>
				</td>
				<td>
					
					<p>Escherichia coli EHEC: method implementation of food samples analysis.</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220075-00</p>
				</td>
				<td>
					
					<p>30.03.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Simone Steiner<br>Tigen Pharma SA<br>Route de la Corniche 6<br>1066 Epalinges</p>
				</td>
				<td>
					
					<p>Technical development of cell therapies</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220076-00</p>
				</td>
				<td>
					
					<p>30.03.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Adrian Egli<br>Departement Biomedizin (DBM), Hebelstrasse, Universitätsspital Basel<br>Hebelstrasse<br>4031 Basel</p>
				</td>
				<td>
					
					<p>Genetic modification of virulent strains</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220077-00</p>
				</td>
				<td>
					
					<p>31.03.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Emil Kendziorra<br>European Biostasis Foundation<br>Industriestrasse 2<br>8197 Rafz</p>
				</td>
				<td>
					
					<p>Lagerung von Zellen/Gewebe</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220078-00</p>
				</td>
				<td>
					
					<p>31.03.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Xi Zhang<br>Superlab Suisse Epalinges SA<br>Route De La Corniche 6<br>1066 Epalinges</p>
				</td>
				<td>
					
					<p>Mise à disposition laboratoires privés</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220079-00</p>
				</td>
				<td>
					
					<p>31.03.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Mirco Schmolke<br>Université de Genève, CMU (Centre Médical Universitaire)<br>1 Rue Michel Servet<br>1211 Genève</p>
				</td>
				<td>
					
					<p>Identification of host restriction factors of zoonotic transmission of influenza A virus</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220080-00</p>
				</td>
				<td>
					
					<p>01.04.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Scott McNeil<br>Universität Basel, <br>Biozentrum / Pharma­zentrum<br>Klingelbergstrasse 50<br>4056 Basel</p>
				</td>
				<td>
					
					<p>Evaluation of immunogenicity of nanoformulations aimed at reducing anti-drug antibody production in enzyme replacement therapy</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220081-00</p>
				</td>
				<td>
					
					<p>04.04.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Salim Kudsadasi<br>Janssen Vaccines | <br>Branch of Cilag GmbH International<br>Rehhagstrasse<br>3018 Bern</p>
				</td>
				<td>
					
					<p>Formulation, Filling and Analytics of Ad.26 based vaccines</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220082-00</p>
				</td>
				<td>
					
					<p>05.04.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Eleni Gourni<br>Universität Bern, Department for BioMedical Research (DBMR)<br>Murtenstrasse<br>3008 Bern</p>
				</td>
				<td>
					
					<p>Cultivation of epithelial and stromal cancer cells for the further in vitro and in vivo evaluation of radiolabeled compounds with the potential to be used for in vivo tumor imaging and therapy</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220083-00</p>
				</td>
				<td>
					
					<p>07.04.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Marine De Lageneste<br>Biosafe Group SA<br>Allée des moulins 3<br>1274 Grens</p>
				</td>
				<td>
					
					<p>Automatisation de thérapie cellulaire pour des clients à partir d’instruments commercialisés</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220084-00</p>
				</td>
				<td>
					
					<p>08.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Cameron Boggon<br>ETHZ, Departement MATL, Laboratory of Soft Materials and Interfaces<br>Vladimir-Prelog-Weg 5<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Bacterial Microoxen: Using bacterial to transport particles</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220085-00</p>
				</td>
				<td>
					
					<p>14.04.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Claudia Daubenberger<br>Swiss Tropical and <br>Public Health Institute<br>Kreuzstrasse 2<br>4123 Allschwil</p>
				</td>
				<td>
					
					<p>Development and validation of molecular based diagnostic tools for viral, bacterial and parasite pathogens</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220086-00</p>
				</td>
				<td>
					
					<p>14.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Matthias Marti<br>Universität Zürich | Institut für Parasitologie<br>Winterthurerstr.<br>8057 Zürich</p>
				</td>
				<td>
					
					<p>Forschung mit Malaria Parasiten vom Genus Plasmodium</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220087-00</p>
				</td>
				<td>
					
					<p>20.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Tobias Beyer<br>Cytosurge<br>Saegereistrasse 25<br>8152 Glattbrugg</p>
				</td>
				<td>
					
					<p>Injection of CRISPR/Cas RNP into cell lines using Fluid FM</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220088-00</p>
				</td>
				<td>
					
					<p>21.04.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Thomas Klimkait<br>Department Biomedizin | Petersplatz | Universität Basel<br>Petersplatz<br>4003 Basel</p>
				</td>
				<td>
					
					<p>Zelluläre Produktion von sicheren, replikationsdefekten SARS-CoV-2 Varianten für die präklinischen Prüfung</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220089-00</p>
				</td>
				<td>
					
					<p>21.04.2022</p>
				</td>
				<td>
					
					<p>ZG</p>
				</td>
				<td>
					
					<p>Michael Glauser<br>Roche Diagnostics International AG<br>Forrenstrasse 2<br>6343 Rotkreuz</p>
				</td>
				<td>
					
					<p>Diagnostische Arbeiten für die Vorentwicklung von prä-/post-analytik Geräten und Analyzer</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220090-00</p>
				</td>
				<td>
					
					<p>22.04.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Athanasios Nenes<br>EPFL – ENAC Faculté <br>de l’Environnement Naturel, Architectural <br>et Construit<br>Station<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>Infectivity of influenza viruses in expiratory aerosols under controlled temperatures, humidities and composition</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220091-00</p>
				</td>
				<td>
					
					<p>22.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Marcy Zenobi-Wong<br>ETHZ, Departement HEST, Gruppe Zenobi-Wong<br>Otto-Stern-Weg 7<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Gene editing on chondrogenic cells</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220092-00</p>
				</td>
				<td>
					
					<p>25.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Guido Christian Greulich<br>A-Labs Switzerland GmbH<br>Kilchbergstrasse 6<br>8134 Adliswil</p>
				</td>
				<td>
					
					<p>Bewilligungsgesuch mikrobiologisches Labor</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220093-00</p>
				</td>
				<td>
					
					<p>25.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Marjan Kraak<br>ETHZ, Innovation and Entrepreneurship Lab<br>Wagistrasse 18<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Globalmeldung für das ieLab, BSL1</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220094-00</p>
				</td>
				<td>
					
					<p>26.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Cristina Porcheri<br>University of Zürich – Center of Dental Medicine<br>Schönleinstrasse 2<br>8032 Zürich</p>
				</td>
				<td>
					
					<p>Oral squamous cell carcinoma – cell lines</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220095-00</p>
				</td>
				<td>
					
					<p>26.04.2022</p>
				</td>
				<td>
					
					<p>FR</p>
				</td>
				<td>
					
					<p>Mona Hassan Abdalla<br>SMF lab<br>Rue Pierre Yerly 10<br>1762 Givisiez</p>
				</td>
				<td>
					
					<p>Laboratoires analyses biomédicales_ETILAB_SMF</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220096-00</p>
				</td>
				<td>
					
					<p>27.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Anita Schöneberg<br>Agroscope (Changins-Wädenswil, Nyon, Conthey, Pully, Cadenazzo)<br>Müller-Thurgau-Strasse<br>8820 Wädenswil</p>
				</td>
				<td>
					
					<p>Sortenanfälligkeitstests gegenüber Pseudomonas syringae pv syringae</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220097-00</p>
				</td>
				<td>
					
					<p>27.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Anne Lüscher<br>ETHZ, Departement CHAB, Institut für Chemie- und Bioingenieurwissenschaften, Functional Materials Labor (FML)<br>Vladimir-Prelog-Weg<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Transfection Experiments</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220098-00</p>
				</td>
				<td>
					
					<p>28.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Cecilia Giunta<br>Kinderspital Zürich | Universitäts-Kinder­klinik<br>Steinwiesstrasse<br>8032 Zürich</p>
				</td>
				<td>
					
					<p>Investigating the pathomechanisms of inherited metabolic and connective tissue disorders by means of novel in vitro CRISPR/Cas9 engineered cellular models</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220099-00</p>
				</td>
				<td>
					
					<p>29.04.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Frederik Hammes<br>ETHZ | Wasserforschungsinstitut EAWAG<br>Überlandstrasse 133<br>8600 Dübendorf</p>
				</td>
				<td>
					
					<p>Legionella Control in Building Plumbing Systems</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220100-00</p>
				</td>
				<td>
					
					<p>29.04.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Tovo David<br>F. Hoffmann-La Roche AG, DTA Immunology and Inflammation<br>Grenzacherstrasse<br>4070 Basel</p>
				</td>
				<td>
					
					<p>Rare Blood Disorders Research Group</p>
				</td>
			</tr>
		</table></div>
<p>L’ordinanza del 9 maggio 2012 sull’impiego confinato (OIConf; RS <i>814.912</i>) costituisce la base giuridica per la pubblicazione.</p>
<p class=" man-text-align-left ">Gli interessati possono consultare gli atti non confidenziali presso l’UFAM, <br>divisione suolo e biotecnologia, Worblentalstrasse 68, 3063 Ittigen <br>(www.umwelt-schweiz.ch).</p>
<p class=" man-text-align-left ">Previo appuntamento presso il Centro di contatto Biotecnologia della Confederazione, UFAM, al n. telefonico +41 58 463 55 99, n. fax +41 58 463 79 78, <br>contact.biotech@bafu.admin.ch.</p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<td>
					
					<p>30 maggio 2022</p>
				</td>
				<td>
					
					<p>Ufficio federale dell’ambiente:</p>
					<p>Centro di contatto Biotecnologia della Confederazione</p>
				</td>
			</tr>
		</table></div>
</div></div></body>
</html>
